This inventor holds 12 USPTO granted patents and 4 published patent applications. Top assignees: Nour Heart, Inc., University of Connecticut, Other. Active years: 1992-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bloomfield, CT (US) (1992 - 1997)
- Edgewater, MD (US) (2010 - 2012)
- Annapolis, MD (US) (2012)
- Vienna, VA (US) (2020 - 2023)
Company Filing History:
6 out of 7 
2 out of 785 
4 out of 834,570 Years Active: 1992-2023
Title: Salwa A Elgebaly: Innovator in Cardiovascular and Neurodegenerative Disease Research
Introduction
Salwa A Elgebaly is a prominent inventor based in Annapolis, MD (US), known for her significant contributions to the fields of cardiovascular and neurodegenerative disease research. With a total of 12 patents, her work focuses on innovative diagnostic and therapeutic approaches that aim to improve patient outcomes in these critical areas.
Latest Patents
Elgebaly's latest patents include groundbreaking inventions such as the "Nourin gene-based RNA molecular network," which provides novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI, and heart failure. This invention offers a method for the early diagnosis and differentiation of ischemic cardiac events, enabling healthcare professionals to better manage patients with these conditions. Another notable patent is for "Cyclocreatine phosphate," a novel bioenergetic therapy designed to prevent and treat ischemia-induced and aging-related cardiovascular and neurodegenerative diseases. This innovative approach preserves cellular energy sources and rejuvenates organ function, thereby maintaining normal physical activity and providing cardioprotection during cardiac procedures.
Career Highlights
Throughout her career, Elgebaly has worked with various companies, including Nour Heart, Inc. Her research and inventions have positioned her as a leader in her field, contributing to advancements that have the potential to transform patient care.
Collaborations
Elgebaly has collaborated with notable professionals in her field, including Elliott Schiffmann and Marwa Matboli Sayed, who have contributed to her research endeavors.
Conclusion
Salwa A Elgebaly's innovative work in the medical field highlights her commitment to advancing diagnostic and therapeutic methods for cardiovascular and neurodegenerative diseases. Her contributions continue to pave the way for improved patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile